A Bayesian pick-the-winner design in a randomized phase II clinical trial

PURPOSE: Many phase II clinical trials evaluate unique experimental drugs/combinations through multi-arm design to expedite the screening process (early termination of ineffective drugs) and to identify the most effective drug (pick the winner) to warrant a phase III trial. Various statistical appro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Chen, Dung-Tsa, Huang, Po-Yu, Lin, Hui-Yi, Chiappori, Alberto A., Gabrilovich, Dmitry I., Haura, Eric B., Antonia, Scott J., Gray, Jhanelle E.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5687612/
https://ncbi.nlm.nih.gov/pubmed/29179442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19088
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados